tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Contineum initiated with an Outperform at Leerink
PremiumThe FlyContineum initiated with an Outperform at Leerink
1M ago
Premium
Ratings
Promising Potential of PIPE-791: Buy Rating for Contineum Therapeutics Amid Positive Phase 1b Results
2M ago
Premium
Ratings
Buy Rating for Contineum Therapeutics’ PIPE-791: Promising Phase 1b Results and Competitive Edge
2M ago
PremiumRatingsStrategic Focus on PIPE-791 Drives Buy Rating for Contineum Therapeutics
3M ago
Contineum reports Q2 EPS (62c), consensus (41c)
Premium
The Fly
Contineum reports Q2 EPS (62c), consensus (41c)
3M ago
Premium
Company Announcements
Contineum Therapeutics Holds 2025 Annual Stockholders Meeting
4M ago
PremiumRatingsPromising Developments at Contineum Therapeutics Signal Undervaluation and Favorable Risk-Reward
6M ago
Premium
Company Announcements
Contineum Therapeutics Reports Q1 2025 Financial Results
6M ago
Premium
Company Announcements
Contineum Therapeutics Files $300M Shelf Registration
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100